






















![]()
Legend Biotech Corporation (LEGN) Q1 2026 Earnings Call May 12, 2026 8:00 AM EDT
Company Participants
Jessie Yeung - Vice President of Finance, Investor & Public Relations
Ying Huang - CEO & Director
Alan Bash - President of CARVYKTI®
Carlos Santos - Chief Financial Officer
Guowei Fang - President of Research & Development
Conference Call Participants
Terence Flynn - Morgan Stanley, Research Division
Umer Raffat - Evercore ISI Institutional Equities, Research Division
Jessica Fye - JPMorgan Chase & Co, Research Division
Konstantinos Biliouris - Oppenheimer & Co. Inc., Research Division
Etzer Darout - Barclays Bank PLC, Research Division
Eric Schmidt - Cantor Fitzgerald & Co., Research Division
James Shin - Deutsche Bank AG, Research Division
Leonid Timashev - RBC Capital Markets, Research Division
Sean McCutcheon - Raymond James & Associates, Inc., Research Division
Ashwani Verma - UBS Investment Bank, Research Division
Yaron Werber - TD Cowen, Research Division
Presentation
Operator
Good day, and thank you for standing by. Welcome to the Legend Biotech First Quarter 2026 Earnings Conference Call.
[Operator Instructions] Today's conference is being recorded. I will now hand the conference over to your speaker host for today, Jessie Yeung, Vice President of Investor Relations and Finance. Please go ahead. Good morning.
Jessie Yeung
Vice President of Finance, Investor & Public Relations
This is Jessie Yeung, Vice President of Investor Relations and Finance at Legend Biotech. Thank you for joining our conference call today to review our first quarter of 2026 performance.
Prior to this call, we issued a press release announcing our financial results for the quarter. You can find the press release on our IR website at legendbiotech.com. Joining me on today's call are Ying Huang, the company's Chief Executive Officer; Alan Bash, the company's President of CARVYKTI; and Carlos Santos, the company's Chief Financial Officer. Following the prepared remarks, we will open up the call for Q&A. We also have our President of R&D, Guowei Fang, joining the Q&A session.
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。